+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Tuberculosis Diagnosis Market - Global Forecast 2026-2032- Product Image
Bovine Tuberculosis Diagnosis Market - Global Forecast 2026-2032- Product Image
Sale

Bovine Tuberculosis Diagnosis Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011093
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bovine Tuberculosis Diagnosis Market is projected to reach USD 1.04 Billion in 2026. It is expected to continue growing at a CAGR of 8.92%, reaching USD 1.74 Billion by 2032.

Bovine tuberculosis diagnosis is a critical component of animal health surveillance, livestock biosecurity, public health protection, and international trade compliance. Caused primarily by Mycobacterium bovis, bovine tuberculosis affects cattle and can infect wildlife reservoirs and humans, making accurate detection essential within One Health frameworks. Diagnostic strategies typically combine field-based screening, laboratory confirmation, herd-level surveillance, abattoir inspection, and epidemiological tracing to identify infection, reduce transmission, and support disease control programs.

The diagnostic landscape includes traditional tuberculin skin testing, interferon-gamma release assays, culture, histopathology, molecular assays such as PCR, and whole-genome sequencing for outbreak investigation and strain characterization. Each method serves a distinct role: skin testing remains widely used for herd screening, laboratory culture provides confirmatory evidence despite long turnaround times, and molecular diagnostics support faster identification where infrastructure and validated protocols are available. Demand for reliable bovine TB testing is being shaped by stricter animal movement rules, food safety requirements, zoonotic disease awareness, and the need to protect dairy and beef supply chains from costly disease disruption.

Transformative Shifts in the Diagnostic Landscape

The bovine tuberculosis diagnosis landscape is undergoing a practical shift from single-test reliance toward integrated, risk-based diagnostic systems. Veterinary authorities and herd managers increasingly combine skin testing, ancillary blood-based assays, post-mortem inspection, and molecular confirmation to improve case detection while managing false positives and false negatives. This shift is especially important in regions where wildlife reservoirs, mixed farming systems, cross-border livestock movement, and variable herd biosecurity complicate eradication efforts.

Another major transformation is the movement toward faster, more traceable, and digitally connected surveillance. Laboratory information systems, electronic animal identification, geospatial mapping, and structured outbreak reporting are improving the ability to link diagnostic findings with animal movement histories and herd-level risk factors. Molecular epidemiology, including sequencing-based strain comparison, is also strengthening source tracing and helping authorities distinguish reintroduction from local persistence. At the same time, diagnostic adoption remains influenced by test validation standards, veterinary workforce capacity, sample transport quality, national compensation policies, and farmer participation in surveillance programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence bovine tuberculosis diagnosis by improving how diagnostic, epidemiological, and surveillance data are interpreted. AI-enabled analytics can support risk scoring for herds, prioritize testing in high-risk zones, identify spatial clusters, and integrate data from animal movements, farm history, wildlife exposure, abattoir findings, and laboratory results. These applications are particularly relevant where veterinary services must allocate limited testing resources across large cattle populations and geographically dispersed farms.

AI also has potential to enhance laboratory and field workflows. Image analysis may support pathology review, automated pattern recognition can assist interpretation of large surveillance datasets, and predictive models can help evaluate the probability of infection under defined epidemiological conditions. However, the cumulative impact of AI depends on data quality, transparent model validation, interoperability with veterinary databases, and clear governance for decision support. In bovine TB control, AI should complement rather than replace validated diagnostic tests, official case definitions, and veterinary judgment.

Key Regional Insights

Asia-Pacific faces diverse bovine tuberculosis diagnosis needs, ranging from intensive dairy systems to smallholder and mixed-species farming environments. Countries with expanding dairy production and dense animal movement networks are emphasizing surveillance, laboratory capacity, and zoonotic disease monitoring, while wildlife-livestock interfaces and variable access to veterinary services influence diagnostic coverage. North America maintains structured bovine TB control programs supported by animal identification, herd testing, movement controls, abattoir surveillance, and laboratory confirmation, with particular attention to wildlife reservoirs and border-related livestock trade requirements.

Latin America’s diagnostic priorities are closely connected to cattle production, dairy safety, export certification, and regional differences in veterinary infrastructure. Programs often rely on tuberculin testing and slaughterhouse inspection, with laboratory confirmation used to support control actions and epidemiological investigation. Europe has long-standing bovine TB surveillance and control frameworks, but diagnostic intensity varies by country depending on herd prevalence, wildlife reservoirs, and national eradication status. The region places strong emphasis on harmonized testing standards, movement regulation, and food chain safety under established animal health legislation.

The Middle East is strengthening animal health surveillance as livestock trade, dairy development, and food security strategies increase the importance of reliable bovine TB detection. Diagnostic implementation is shaped by import controls, veterinary laboratory readiness, and the need to monitor transboundary animal disease risks. Africa carries high One Health relevance for bovine tuberculosis diagnosis due to close contact between cattle, wildlife, and people in many settings, combined with variable access to laboratory diagnostics. Surveillance enhancement, field-applicable testing, veterinary workforce development, and integration with human TB awareness are central to improving detection across the region.

Key Group Insights

ASEAN countries present a highly varied bovine tuberculosis diagnosis environment, with intensive dairy operations, smallholder cattle systems, and cross-border animal movement creating a need for coordinated surveillance and practical field diagnostics. Regional priorities include strengthening veterinary laboratories, improving traceability, and aligning animal health monitoring with food safety and zoonotic disease prevention. The GCC’s diagnostic focus is shaped by livestock import dependence, food security programs, and controlled dairy production systems, where quarantine testing, health certification, and laboratory-backed surveillance play important roles.

The European Union operates within a highly regulated animal health framework that supports harmonized testing, movement controls, eradication programs, and official disease status recognition. Diagnostic strategies are closely tied to veterinary legislation, trade rules, and risk-based surveillance. BRICS countries show wide differences in cattle population structure, veterinary infrastructure, and disease control maturity, but collectively emphasize the importance of scalable diagnostics, molecular confirmation, and surveillance systems that can support large and complex livestock sectors.

G7 countries generally maintain advanced veterinary surveillance capacity, laboratory networks, digital reporting systems, and structured bovine TB control policies, while continuing to address persistent challenges such as wildlife reservoirs, farm-level biosecurity gaps, and test performance limitations. NATO member countries overlap significantly with high-capacity veterinary systems in North America and Europe, where disease preparedness, biosecurity, and resilient food supply chains reinforce the importance of accurate bovine tuberculosis diagnosis within broader animal health security planning.

Key Country Insights

The United States and Canada maintain formal bovine tuberculosis surveillance systems using herd testing, slaughter surveillance, epidemiological investigation, and movement controls, with diagnostic attention focused on maintaining disease control status and managing wildlife-associated risks. Mexico’s diagnostic landscape is strongly linked to cattle trade, regional control programs, and certification requirements, making reliable tuberculin testing, inspection, and laboratory confirmation essential. Brazil’s large cattle sector creates a need for scalable disease surveillance, particularly in dairy and beef production areas where herd health and export confidence are priorities.

The United Kingdom has a high-profile bovine TB challenge, especially where cattle infection intersects with wildlife reservoirs, leading to intensive testing regimes, movement restrictions, and ongoing evaluation of diagnostic strategies. Germany and France operate under structured European animal health frameworks, with surveillance intensity shaped by official disease status, movement compliance, and veterinary monitoring. Russia’s large geography and varied livestock systems require regionally adaptable bovine TB diagnostic approaches, while Italy and Spain maintain surveillance systems aligned with European regulatory requirements and national animal health programs.

China and India have significant relevance for bovine tuberculosis diagnosis due to large cattle and buffalo populations, expanding dairy demand, and One Health concerns related to zoonotic transmission. Diagnostic priorities include surveillance expansion, laboratory strengthening, and field-compatible testing pathways. Japan and South Korea emphasize regulated animal health systems, import safeguards, and high biosecurity standards, supporting structured testing and rapid response capability. Australia benefits from a strong animal health surveillance culture and biosecurity controls, with bovine TB diagnosis positioned as part of continued vigilance to protect livestock health, trade access, and public confidence.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated, fit-for-purpose diagnostic strategies that combine field screening with confirmatory laboratory methods. Test selection should account for herd risk, regulatory requirements, animal movement patterns, wildlife exposure, and the consequences of false diagnostic outcomes. Investment in sample logistics, laboratory quality management, proficiency testing, and standardized reporting can improve confidence in results and support timely disease control decisions.

Stakeholders should also strengthen data integration across farms, veterinary authorities, laboratories, abattoirs, and movement databases. Digital traceability and geospatial risk analysis can help identify infection pathways and optimize surveillance coverage. Partnerships between veterinary services, livestock producers, public health agencies, and wildlife authorities are essential where bovine TB persists across species boundaries. For organizations adopting AI or advanced analytics, leaders should ensure model transparency, independent validation, data governance, and alignment with official diagnostic protocols.

Research Methodology

This executive summary is developed using a secondary research approach grounded in verified animal health, veterinary diagnostics, and public health sources. The methodology emphasizes evidence from official veterinary authorities, intergovernmental animal health guidance, peer-reviewed scientific literature, national surveillance documentation, regulatory frameworks, and recognized One Health resources. Insights are synthesized to describe diagnostic practices, regional priorities, technology trends, and operational considerations without relying on market sizing, market estimation, market share, or forecasting.

The analysis focuses on the role of established and emerging diagnostic tools, including tuberculin skin testing, interferon-gamma assays, microbiological culture, molecular detection, pathology, sequencing, and digital surveillance. Regional and country-level interpretations are derived from documented disease control structures, livestock system characteristics, trade and biosecurity requirements, and known epidemiological factors such as wildlife reservoirs and cross-border animal movement. All conclusions are framed to support strategic understanding of bovine tuberculosis diagnosis rather than commercial volume prediction.

Conclusion

Bovine tuberculosis diagnosis remains central to animal health protection, zoonotic disease prevention, and resilient livestock production. The sector is moving toward integrated diagnostic ecosystems that combine field testing, laboratory confirmation, digital traceability, molecular epidemiology, and risk-based surveillance. While long-established tools such as tuberculin testing continue to play a major role, the growing use of molecular diagnostics, sequencing, data analytics, and AI-enabled decision support is improving the precision and responsiveness of control programs.

Future progress will depend on test validation, laboratory capacity, farmer engagement, wildlife-livestock management, and harmonized reporting across jurisdictions. Regions and countries with strong surveillance infrastructure are focusing on persistence, traceability, and rapid response, while emerging systems are prioritizing access, scalability, and One Health integration. For industry leaders, the most effective path forward is to strengthen diagnostic reliability, connect surveillance data, and align technology adoption with official veterinary standards and practical field realities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bovine Tuberculosis Diagnosis Market, by Test Type
7.1. Introduction
7.2. Caudal Fold Test
7.2.1. Comparative Intradermal Cervical Test
7.2.2. Single Intradermal Cervical Test
7.3. Elisa
7.4. Gamma Interferon Assay
7.5. PCR
8. Bovine Tuberculosis Diagnosis Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Kits
8.3.1. Caudal Fold Test Kits
8.3.2. Elisa Kits
8.3.3. Gamma Interferon Assay Kits
8.3.4. PCR Kits
8.4. Reagents
8.4.1. Antigens
8.4.2. Enzymes
8.4.3. Primers And Probes
9. Bovine Tuberculosis Diagnosis Market, by Sample Type
9.1. Introduction
9.2. Blood Samples
9.2.1. Whole Blood
9.2.2. Serum
9.2.3. Plasma
9.3. Milk Samples
9.4. Tissue And Lesion Samples
9.4.1. Lymph Node Tissue
9.4.2. Organ And Lesion Tissue
9.5. Respiratory And Swab Samples
9.5.1. Nasal Swabs
9.5.2. Bronchoalveolar Lavage Fluid
10. Bovine Tuberculosis Diagnosis Market, by Technology
10.1. Introduction
10.2. Immunodiagnostic Technology
10.3. Molecular Diagnostic Technology
10.4. Microbiological Technology
10.5. Automation Technology
11. Bovine Tuberculosis Diagnosis Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Government Agencies
11.4. Research Institutes
11.5. Veterinary Hospitals
12. Bovine Tuberculosis Diagnosis Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Bovine Tuberculosis Diagnosis Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bovine Tuberculosis Diagnosis Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. AdvaCare Pharma
16.3. Akonni Biosystems Inc
16.4. Bio-Rad Laboratories Inc
16.5. bioMérieux SA
16.6. Bionote Inc
16.7. Bruker Corporation
16.8. Creative Diagnostics
16.9. Enfer Group
16.10. Genedrive PLC
16.11. Hangzhou Frenovo Biotech Co Ltd
16.12. IDEXX Laboratories Inc
16.13. Innovative Diagnostics SAS
16.14. Lionex GmbH
16.15. Molbio Diagnostics Private Limited
16.16. Mylab Discovery Solutions Pvt Ltd
16.17. Neogen Corporation
16.18. PBD Biotech Ltd
16.19. QIAGEN NV
16.20. Randox Food Diagnostics
16.21. Ring Biotechnology Co Ltd
16.22. Sansure Biotech Inc
16.23. SD Biosensor Inc
16.24. Seegene Inc
16.25. Shenzhen Bioeasy Biotechnology Co Ltd
16.26. Thermo Fisher Scientific Inc
16.27. Vimian Group AB
16.28. Zoetis Inc
List of Figures
FIGURE 1. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CAUDAL FOLD TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CAUDAL FOLD TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CAUDAL FOLD TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COMPARATIVE INTRADERMAL CERVICAL TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COMPARATIVE INTRADERMAL CERVICAL TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COMPARATIVE INTRADERMAL CERVICAL TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SINGLE INTRADERMAL CERVICAL TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SINGLE INTRADERMAL CERVICAL TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SINGLE INTRADERMAL CERVICAL TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL GAMMA INTERFERON ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL GAMMA INTERFERON ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL GAMMA INTERFERON ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CAUDAL FOLD TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CAUDAL FOLD TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CAUDAL FOLD TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ELISA KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ELISA KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ELISA KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GAMMA INTERFERON ASSAY KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GAMMA INTERFERON ASSAY KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL GAMMA INTERFERON ASSAY KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANTIGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ANTIGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ANTIGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PRIMERS AND PROBES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PRIMERS AND PROBES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PRIMERS AND PROBES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SERUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SERUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SERUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MILK SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MILK SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MILK SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TISSUE AND LESION SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL TISSUE AND LESION SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TISSUE AND LESION SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL LYMPH NODE TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL LYMPH NODE TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL LYMPH NODE TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ORGAN AND LESION TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ORGAN AND LESION TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ORGAN AND LESION TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY AND SWAB SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY AND SWAB SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY AND SWAB SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL NASAL SWABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL NASAL SWABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NASAL SWABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BRONCHOALVEOLAR LAVAGE FLUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BRONCHOALVEOLAR LAVAGE FLUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL BRONCHOALVEOLAR LAVAGE FLUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNODIAGNOSTIC TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNODIAGNOSTIC TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNODIAGNOSTIC TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL MOLECULAR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MOLECULAR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MOLECULAR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MICROBIOLOGICAL TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MICROBIOLOGICAL TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL MICROBIOLOGICAL TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL AUTOMATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL AUTOMATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL AUTOMATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GOVERNMENT AGENCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GOVERNMENT AGENCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GOVERNMENT AGENCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 153. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 154. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 155. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 156. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 158. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 159. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. EUROPE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 177. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 178. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 179. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 180. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 181. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 182. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 183. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 184. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. AFRICA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 189. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 190. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 191. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 192. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 193. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 194. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 195. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 196. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 197. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. ASEAN BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 201. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 202. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 203. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 204. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 205. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 206. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 207. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 208. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 209. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. GCC BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 225. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 226. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 227. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 228. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 229. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 230. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 231. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 232. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 233. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. BRICS BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 237. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 238. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 239. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 240. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 241. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 242. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 243. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 244. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 245. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. G7 BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 249. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 250. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 251. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 252. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 253. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 254. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 255. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 256. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 257. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. NATO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. GLOBAL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 274. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 275. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 276. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 277. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 278. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 279. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 280. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 281. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 282. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. CANADA BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 286. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 287. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 288. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 289. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 290. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 291. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 292. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 293. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 294. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. MEXICO BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 322. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 323. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 324. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 325. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 326. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 327. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY BLOOD SAMPLES, 2017-2032 (USD MILLION)
TABLE 328. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TISSUE AND LESION SAMPLES, 2017-2032 (USD MILLION)
TABLE 329. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY RESPIRATORY AND SWAB SAMPLES, 2017-2032 (USD MILLION)
TABLE 330. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 331. GERMANY BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 332. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 334. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY CAUDAL FOLD TEST, 2017-2032 (USD MILLION)
TABLE 335. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 336. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 337. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 338. FRANCE BOVINE TUBERCULOSIS DIAGNOSIS MARKET SIZE, BY SAMPLE T

Companies Mentioned

  • Abbott Laboratories
  • AdvaCare Pharma
  • Akonni Biosystems Inc
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Bionote Inc
  • Bruker Corporation
  • Creative Diagnostics
  • Enfer Group
  • Genedrive PLC
  • Hangzhou Frenovo Biotech Co Ltd
  • IDEXX Laboratories Inc
  • Innovative Diagnostics SAS
  • Lionex GmbH
  • Molbio Diagnostics Private Limited
  • Mylab Discovery Solutions Pvt Ltd
  • Neogen Corporation
  • PBD Biotech Ltd
  • QIAGEN NV
  • Randox Food Diagnostics
  • Ring Biotechnology Co Ltd
  • Sansure Biotech Inc
  • SD Biosensor Inc
  • Seegene Inc
  • Shenzhen Bioeasy Biotechnology Co Ltd
  • Thermo Fisher Scientific Inc
  • Vimian Group AB
  • Zoetis Inc

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.04 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.74 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Bovine Tuberculosis Diagnosis - Global Strategic Business Report - Product Image

Bovine Tuberculosis Diagnosis - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
Bovine Tuberculosis Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Bovine Tuberculosis Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Veterinary Infectious Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Veterinary Molecular Diagnostics - Global Strategic Business Report - Product Image

Veterinary Molecular Diagnostics - Global Strategic Business Report

  • Report
  • 570 Pages
  • Global
From
Large Animal Clinical Procedures for Veterinary Technicians. Edition No. 4 - Product Image

Large Animal Clinical Procedures for Veterinary Technicians. Edition No. 4

  • Book

About the Bovine Tuberculosis Diagnosis Market

The Bovine Tuberculosis (TB) Diagnosis market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of TB in cattle, which is a major cause of economic losses in the livestock industry. Diagnosis of TB in cattle is typically done through a combination of clinical signs, laboratory tests, and post-mortem examination. Tests used to diagnose TB in cattle include the single intradermal comparative cervical tuberculin test, the single intradermal comparative cervical tuberculin test with gamma interferon, and the single intradermal comparative cervical tuberculin test with gamma interferon and ELISA. The Bovine Tuberculosis Diagnosis market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include IDEXX Laboratories, Inc., Neogen Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Zoetis, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.